CNS Sarcoidosis and Acthar Gel

PHASE4CompletedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

November 30, 2020

Study Completion Date

November 30, 2020

Conditions
CNS Sarcoidosis
Interventions
DRUG

H.P. Acthar Gel

80 IU subcutaneously daily for 10 days then followed by 80 IU subcutaneously three times per week through Month 12

Trial Locations (1)

21201

University of Maryland, Baltimore, Baltimore

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Mallinckrodt

INDUSTRY

lead

University of Maryland, Baltimore

OTHER